Glycyrrhetic acid‐loaded microparticles: liver‐specific delivery and therapeutic potential against carbon tetrachloride‐induced hepatitis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2004-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1211/0022357023132PMID 15099438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE PHARMACOKINETICS OF GLYCYRRHIZIC ACID EVALUATED BY PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING†

  2001cited by this paper
• Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.

  2000cited by this paper
• In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers

  1997cited by this paper
• Bioavailability Study of Glycyrrhetic Acid after Oral Administration of Glycyrrhizin in Rats; Relevance to the Intestinal Bacterial Hydrolysis

  1996cited by this paper
• Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation.

  1993cited by this paper
• Factors influencing the profiles of TRH release from copoly(d,l-lactic/glycolic acid) microspheres

  1991cited by this paper
• Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats.

  1989influential reference
• In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.

  1988cited by this paper
• Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.

  1988cited by this paper
• Biliary excretion and enterohepatic cycling of glycyrrhizin in rats.

  1986cited by this paper
• Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin.

  1985cited by this paper
• Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives.

  1985cited by this paper
• Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin.

  1982cited by this paper
• Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats.

  1981cited by this paper
• Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.

  1981cited by this paper
• Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and m1crospherical carriers of gelatin

  1981cited by this paper
• Clearance of 141C3-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs.

  1980cited by this paper
• Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1

  1979cited by this paper
• Drug-carrier property of albumin microspheres in chemotherapy. II. Preparation and tissue distribution in mice of microsphere-entrapped 5-fluorouracil.

  1979cited by this paper
• Transaminase activity in human blood.

  1955cited by this paper

• Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury

  2020cites this paper
• Preparation and Evaluation of Methoxypolyethylene Glycol-Poly (DL-Lactic Acid) Nanoparticles Loaded with Glycyrrhetic Acid

  2016cites this paper
• Self-assembly of polyion complex nanocarriers from ammonium glycyrrhizinate and monomethoxy poly(ethylene glycol)-b-poly(γ-amino-ε-caprolactone).

  2013cites this paper
• Glycyrrhetinic Acid-Poly(ethylene glycol)-glycyrrhetinic Acid Tri-Block Conjugates Based Self-Assembled Micelles for Hepatic Targeted Delivery of Poorly Water Soluble Drug

  2013cites this paper
• AN INVESTIGATION OF THE METABOLISM OF LIQUIRITIN AND THE IMMUNOLOGICAL EFFECTS OF ITS METABOLITES

  2012cites this paper
• Curative Effect of 18β-Glycyrrhetinic Acid in Experimental Visceral Leishmaniasis Depends on Phosphatase-Dependent Modulation of Cellular MAP Kinases

  2011cites this paper
• Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: Characterization and in vitro and in vivo evaluation

  2010cites this paper
• Particle Characteristics and Biodistribution of Camptothecin-Loaded PLA/(PEG-PPG-PEG) Nanoparticles

  2008cites this paper
• In Vitro and In Vivo Evaluation of Microparticulate Drug Delivery Systems Composed of Macromolecular Prodrugs

  2008cites this paper
• In‐vitro and in‐vivo evaluation of oligoethylene esters as dermal prodrugs of 18β‐glycyrrhetic acid

  2006cites this paper
• Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles.

  2006cites this paper
• In-vitro and in-vivo evaluation of oligoethylene esters as dermal prodrugs of 18beta-glycyrrhetic acid.

  2006cites this paper
• Preparation and evaluation of glycyrrhetic acid‐containing microparticles as an anti‐hepatotoxic system

  2005influential citation
• Novel delivery methods for treatment of viral hepatitis: an update

  2005cites this paper